Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Evan, Blank"'
Publikováno v:
Journal of the American College of Cardiology. 81:3908
Autor:
Rand Ibrahim, Evan Blank, Neal K. Bhatia, Anand D. Shah, Stacy Westerman, David B. De Lurgio, Christine Tompkins, Anshul M. Patel, Angel R. Leon, Faisal M. Merchant, Mikhael Faris El Chami, Michael Shane Lloyd, Soroosh Kiani
Publikováno v:
Journal of the American College of Cardiology. 81:215
Publikováno v:
The Journal of Innovations in Cardiac Rhythm Management
Publikováno v:
CASE : Cardiovascular Imaging Case Reports
Graphical abstract
Highlights • Left atrial myxomas can cause pulmonary hypertension and right-sided heart failure. • TTE can be used to identify an atrial mass and quantify its hemodynamic effects. • Excision of atrial myxoma is indicated
Highlights • Left atrial myxomas can cause pulmonary hypertension and right-sided heart failure. • TTE can be used to identify an atrial mass and quantify its hemodynamic effects. • Excision of atrial myxoma is indicated
Publikováno v:
Heart Rhythm. 18:S165-S166
Publikováno v:
Circulation. 142
Introduction: Implantable cardioverter defibrillator (ICD) implantation in patients with cardiac amyloidosis is controversial, with no clear guidelines for clinical decision-making.. The role of ICD implantation in hereditary Transthyretin Amyloid Ca
Publikováno v:
Journal of the American College of Cardiology. 77:825
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S240
Purpose Hereditary Transthyretin Cardiac Amyloidosis (hATTR- CM) is an infiltrative cardiomyopathy that is usually associated with significant ventricular hypertrophy and restrictive diastolic dysfunction. Recent studies have demonstrated that patien
Publikováno v:
Journal of the American College of Cardiology. 75:2625
Atrioesophageal Fistula (AEF) is a rare complication of Atrial Fibrillation (AF) ablation. Mortality in this population remains very high, requiring timely diagnosis and a multidisciplinary approach to treatment. A 61 year old male with a history of
Autor:
Evan Blank, Alexander W Peters, David J. Heller, Mahesh K Vidula, Sandeep P. Kishore, Rajesh Vedanthan, Matthew Price, Valentin Fuster, Mark D. Huffman, Amisha Patel, Oyere K Onuma
Publikováno v:
Journal of the American College of Cardiology. 71(5)
The World Health Organization (WHO) Model List of Essential Medicines (EML) is a key tool for improving global access to medicines for all conditions, including cardiovascular diseases (CVDs). The WHO EML is used by member states to determine their n